NS
Navneet Singh Thakur
About Navneet Singh Thakur
Data last updated:
Navneet Singh Thakur is a Director at Axolab Formulations Private Limited (since 2022) and Director at Capiq Pharmaceuticals Private Limited (since 2022). The companies operate in Chemicals and Pharma. The largest current company by reported revenue is Axolab Formulations Private Limited at ₹5.29 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 28 Sep 2022 | 2022 | ₹5.29 Cr (FY 2025) | Active | |
| Director | 27 Jun 2022 | 2022 | Active |
Board colleagues of Navneet Singh Thakur
| Name | DIN | Company | Designation |
|---|---|---|---|
| Munish Goyal | 03154493 | Axolab Formulations Private Limited , Capiq Pharmaceuticals Private Limited | Director |
| Nishant Mehta | 10119645 | Axolab Formulations Private Limited | Director |
| Sarthak Goyal | 10011044 | Axolab Formulations Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Navneet Singh Thakur
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Navneet Singh Thakur
Navneet Singh Thakur currently holds 2 directorships: Axolab Formulations Private Limited (Director, since 28 Sep 2022, revenue ₹5.29 Cr (FY 2025)); Capiq Pharmaceuticals Private Limited (Director, since 27 Jun 2022).
Navneet Singh Thakur was first appointed on 27 Jun 2022 as Director at Capiq Pharmaceuticals Private Limited.
The current boards of Navneet Singh Thakur's companies include Munish Goyal (Axolab Formulations Private Limited), Nishant Mehta (Axolab Formulations Private Limited), Sarthak Goyal (Axolab Formulations Private Limited).